CAPPED BONUSZERTIFIKAT - STRYKER CORP. Stock

Certificat

DE000PC5RUD3

Market Closed - Boerse Frankfurt Warrants 15:40:10 2024-05-10 EDT
277.8 EUR +0.09% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-0.66%
1 month-1.31%
Date Price Change Volume
24-05-10 277.8 +0.08% 0
24-05-09 277.6 +0.15% 0
24-05-08 277.2 -0.60% 0
24-05-07 278.8 +1.13% 0
24-05-06 275.7 -0.02% 0

Real-time Boerse Frankfurt Warrants

Last update May 10, 2024 at 03:40 pm

More quotes

Static data

Product typeBonus- und Teilschutz-Zertifikate
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RUD
ISINDE000PC5RUD3
Date issued 2024-02-27
Strike 360 $
Maturity 2025-12-19 (587 Days)
Parity 1 : 1
Emission price 275.9
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 284.5
Lowest since issue 273.9
Spread 0.5
Spread %0.18%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW